Machine Learning-Based Identification of Candidate Serum miRNA Features for Pan-Cancer and Cancer Type Classification
Open Access
Abstract
MicroRNA (miRNA) regulation plays a pivotal role in intracellular gene expression. Analysis of miRNA profiles can provide critical insights into disease states. As cancer-associated molecules reported in previous studies, miRNAs may serve as candidate classificatory features for exploratory cancer classification. This research analyzed serum miRNA data from patients with 13 solid cancer types and individuals without cancer. The study comprised two distinct analyses: first, stratifying the dataset into cancer and non-cancer groups to identify miRNAs differentially represented in cancer patients; and second, subdividing the cancer patient data into 13 predefined solid-cancer types to identify candidate miRNA features that discriminate among these cancer types. We employed seven feature-ranking algorithms to evaluate miRNA contributions in both analyses and generate feature lists. Each list was examined using an incremental feature selection method to extract essential miRNAs and build good-performing classification models. Several candidate miRNAs were identified for distinguishing pan-cancer samples from non-cancer ones: miR-4783-3p has been linked to associated with the regulation of endocrine cell differentiation, and miR-663a has been reported in hepatocellular carcinoma and thyroid carcinoma. The analysis also highlighted miRNAs that differentiate solid cancer types, including miR-629-3p, reported to be upregulated in lung and breast cancer, and miR-6087, reported to be downregulated in osteosarcoma and bladder cancer.Keywords
Funding Information
- Major Project of Guangzhou National Laboratory (GZNL2024A01003)
- Fund of the Key Laboratory of Tissue Microenvironment and Tumor of Chinese Academy of Sciences (202002)
- Natural Science Foundation of Shandong Province (ZR2022MC072)
This publication has 143 references indexed in Scilit:
- CERS6‐AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR‐195‐5p/WIPI2 axisThe Kaohsiung Journal of Medical Sciences, 2022
- The potential role of miR‐1290 in cancer progression, diagnosis, prognosis, and treatment: An oncomiR or onco‐suppressor microRNA?Journal of Cellular Biochemistry, 2021
- Novel long noncoding RNA LINC02323 promotes cell growth and migration of ovarian cancer via TGF‐β receptor 1 by miR‐1343‐3pJournal of Clinical Laboratory Analysis, 2020
- Profiling and integrated analysis of differentially expressed circRNAs as novel biomarkers for breast cancerJournal of Cellular Physiology, 2020
- Assessment of the Diagnostic Utility of Serum MicroRNA Classification in Patients With Diffuse GliomaJAMA Network Open, 2019
- Long noncoding RNA LINC00473 drives the progression of pancreatic cancer via upregulating programmed death‐ligand 1 by sponging microRNA‐195‐5pJournal of Cellular Physiology, 2019
- Application of a Neural Network Whole Transcriptome–Based Pan-Cancer Method for Diagnosis of Primary and Metastatic CancersJAMA Network Open, 2019
- LASSO regressionBritish Journal of Surgery, 2018
- Oncogene RNA helicase DDX6 promotes the process of c‐Myc expression in gastric cancer cellsMolecular Carcinogenesis, 2018
- miR‐145, miR‐133a and miR‐133b: Tumor‐suppressive miRNAs target FSCN1 in esophageal squamous cell carcinomaInternational Journal of Cancer, 2010